• CSL Plasma Inc.

Company Profile

CSL Plasma is steeped in a tradition of innovation and excellence. We’re a wholly owned subsidiary of CSL Behring, headquartered in King of Prussia, Pennsylvania. Other facilities include a manufacturing plant in Kankakee, Illinois, and facilities in Marburg, Germany and Bern, Switzerland. The Behring name honors the scientific efforts by founder Emil von Behring, whose serum therapy was awarded the Nobel Prize in 1901. CSL Plasma and CSL Behring are owned by a larger group, CSL Limited, based in Melbourne, Australia. CSL first began in 1916 by supplying vaccines for the Australian government. In 1994, CSL became a public company, listed on the Australian Stock Exchange. Since then, CSL Limited has grown rapidly to become a successful and well-respected global specialty biopharmaceutical company. CSL currently employs over 7000 associates worldwide.

CSL Plasma, an industry leader, is passionate about setting and maintaining the highest standards in every aspect of our organization and we believe this begins with our employees.A career with CSL Plasma means being part of a team that is dedicated to improving and saving lives, while at the same time allowing individuals to develop career skills in the healthcare industry.

Show MoreShow Less

Currently Available Positions

VIEW ALL